COBAS AMPLICOR CHLAMYDIA TACHOMATIS TEST 20757497122

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2011-06-28 for COBAS AMPLICOR CHLAMYDIA TACHOMATIS TEST 20757497122 manufactured by Roche Molecular Systems.

Event Text Entries

[2071791] A customer site in (b)(6) alleged that false (b)(6) results were generated during a comparison study with the cobas amplicor chlamydia trachomatis test. (b)(4) they ran previously run (b)(6) samples on three of their instruments and generated discrepant results. The samples had been stored at 2-8 degrees for one day then were frozen at -20 degrees.
Patient Sequence No: 1, Text Type: D, B5


[9153539] A definitive conclusion cannot be drawn at this time, as the investigation into this issue is ongoing. The outcome of the investigation will be communicated through a follow-up report. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[16533626] Hold - sda
Patient Sequence No: 1, Text Type: D, B5


[16564340] Device evaluated by manufacturer: yes. Result: device performed according to specifications. Conclusion: failure detected and product within specification. Urine samples from two patients previously generated positive ct results. Upon retesting for a comparison study, negative results were obtained for some replicates. The samples had been stored at 2-8c for one day and then were frozen at -20c. The customer reported that the patients whose samples produced the discrepant results were not adversely affected. The customer was not willing to provide any further information for the investigation, including kit lot numbers or laboratory statistics (e. G. False positive rate, false negative rate, prevalence of ct infection, etc). No patient samples were provided for investigative testing. Based on the limited available information, no product non-conformance was identified. The issue of discrepant ct results with the cobas amplicor ct/ng test is plausible and may be within the product labeling claims, depending on the laboratory's positive predictive value (ppv), negative predictive value (npv), false positive rate, false negative rate, and number of samples tested. Labeling provides a number of possible sources of discrepant results, such as patient factors, state of infection, and prevalence of infection. Product labeling states sensitivity for female urine specimens was, on average, 90. 6% and for male specimens 89. 1%. It is also noted that the sensitivity was lower for frozen male urine specimens and higher for frozen female urine specimens, as compared to specimens which had not been frozen. It is unknown whether the two samples which generated discrepant results were male or female. The customer did not provide any statistics that could be used to determine if the discrepant results generated were within product labeling claims. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2243471-2011-00068
MDR Report Key2142203
Report Source05
Date Received2011-06-28
Date of Report2011-06-01
Date of Event2011-03-15
Date Mfgr Received2011-06-01
Date Added to Maude2012-02-13
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactVINCENT STAGNITTO
Manufacturer Street1080 US HWY 202S
Manufacturer CityBRANCHBURG NJ 088763733
Manufacturer CountryUS
Manufacturer Postal088763733
Manufacturer Phone9082537569
Single Use0
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOBAS AMPLICOR CHLAMYDIA TACHOMATIS TEST
Generic NameDNA PROBE, NUCLEIC ACID AMPLIFICATION, CHLAMYDIA
Product CodeMKZ
Date Received2011-06-28
Catalog Number20757497122
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerROCHE MOLECULAR SYSTEMS
Manufacturer Address1080 US HW 202S BRANCHBURG NJ 08876373 US 08876 3733


Patients

Patient NumberTreatmentOutcomeDate
10 2011-06-28

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.